MEDP
$455.15
Medpace Holdings, Inc.
Recent News
Illumina Stock Sees RS Rating Jump To 82
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Illumina stock cleared that benchmark Monday, with a jump from 77 to 82 Monday. Hone Your Stock-Picking Skills By Focusing On These Factors This unique rating measures market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.
Is Medpace Holdings (MEDP) Still Attractive After Mixed Share Price Performance This Year
If you are wondering whether Medpace Holdings is still fairly priced after its recent run, this article will walk through what the numbers are really saying about its current value. The stock closed at US$450.41, with returns of 5.2% over the last 30 days, a 21.1% decline year to date and a 38.6% gain over the past year, which gives a mixed picture of momentum and changing risk perceptions. Recent news around contract research organizations and clinical development outsourcing has kept...
Medpace (MEDP) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Medpace (MEDP) closed at $478.54, marking a +1.69% move from the previous day.
2 Healthcare Stocks with Exciting Potential and 1 We Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 5.7%, nearly mirrorring the S&P 500.
3 Profitable Stocks for Long-Term Investors
Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting themselves up for long-term success.